FIELD: chemicopharmaceutical industry. SUBSTANCE: the suggested medicinal form suppositories contains as active components, g: ethionamide 0.175, isoniazide 0.175, pyridoxine hydrochloride 0.03 and, also, complex fatty foundation 2.62. The present innovation enables to avoid inactivation of preparations with gastro-intestinal enzymes, hepatic metabolism and unfavorable action upon the body. Combination of isoniazide of high bacteriostatic activity and ethionamide that increases therapeutic effect of isoniazide and affect refractory and atypical forms of tubercular mycobacteria enables to decrease therapeutic doses of preparations applied. EFFECT: higher efficiency of application. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
COMPOSITE PHARMACEUTICAL COMPOSITION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247561C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
PHARMACEUTICAL COMPOSITION WITH ANTI-TUBERCULOSIS EFFECT | 2006 |
|
RU2332216C2 |
ANTI-TUBERCULOSIS MEDICATION | 2010 |
|
RU2424809C1 |
COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2431487C2 |
Authors
Dates
2004-03-27—Published
2002-11-29—Filed